Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |